Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 3 - What They Never Told You

Chart of the Day: Boson Scientific - Revenue Growth Potential

The Chart of the Day belongs to the healthcare company Boston Scientific (BSX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart...

Barchart

Markets Today: Stocks Climb on M&A Activity and Lower Bond Yields

Morning Markets March E-Mini S&P 500 futures (ES H24) are up +0.06%, and March Nasdaq 100 E-Mini futures (NQH2 4) are up +0.18%. Stock index futures this morning are moderately higher. An increase in M&A activity supports stocks after Boston Scientific agreed to buy Axionics for $3.7 billion and Johnson...

Barchart

3 Top-Rated Growth Stocks To Buy on Every Dip

Growth stocks are down, but don't count them out. Here are three top-rated names worth scooping up when the market pulls back.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Chart of the Day: Boston Scientific - Medical Technology

The Chart of the Day belongs to the medical technology company Boston Scientific (BSX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the...

Barchart

Texas biotech company, UT win $42 million patent case against Boston Scientific

A small Dallas biotech company and the University of Texas took on big pharma and won.

Tribune News Service

Johnson & Johnson reaches $300m settlement over pelvic mesh implants

Settlement of two Australian class actions is largest in country’s history and subject to federal court approval

The Guardian - AU

Coinbase Global, T-Mobile US And 2 Other Stocks Insiders Are Selling

U.S. crude oil futures traded lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Accenture And 3 Other Stocks Insiders Are Selling

Johnson & Johnson (NYSE: JNJ) reported upbeat earnings for its second quarter, but lowered its FY22 guidance. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Boston Scientific to pay $105m to Australian women who received pelvic mesh implants

Lawyer says settlement will provide compensation for women who suffered pain and complications from pelvic mesh

The Guardian - AU

How Is The Market Feeling About Boston Scientific?

Boston Scientific's (NYSE:BSX) short percent of float has risen 25.0% since its last report. The company recently reported that it has 19.02 million shares sold short, which is 1.35% of all regular shares that are available for trading.

Benzinga

Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.66% on an annualized basis producing an average annual return of 20.68%. Currently, Boston Scientific has a market capitalization of $54.31 billion.

Benzinga

5 Analysts Have This to Say About Boston Scientific

Over the past 3 months, 5 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Boston Scientific Buys Substantial Stake In Korean MedTech Player

Boston Scientific Corporation (NYSE:BSX) has agreed to purchase Synergy Innovation Co Ltd's majority stake (~64%) of M.I.Tech Co Ltd, a publicly-traded Korean manufacturer, and distributor of medical devices for endoscopic and urologic procedures. The deal is valued at KRW 14,500 per share, representing KRW 291.2 billion or approximately $230 million. M.I.Tech offers HANAROSTENT technology, a…

Benzinga

Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 10 Years

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.09% on an annualized basis producing an average annual return of 20.41%. Currently, Boston Scientific has a market capitalization of $53.12 billion.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Peering Into Boston Scientific's Recent Short Interest

Boston Scientific's (NYSE:BSX) short percent of float has risen 20.45% since its last report. The company recently reported that it has 15.00 million shares sold short, which is 1.06% of all regular shares that are available for trading.

Benzinga

Where Boston Scientific Stands With Analysts

Boston Scientific (NYSE:BSX) has observed the following analyst ratings within the last quarter:

Benzinga

If You Invested $1000 In Boston Scientific 10 Years Ago, Here's How Much You Would Have Today

Boston Scientific (NYSE:BSX) has outperformed the market over the past 10 years by 9.68% on an annualized basis producing an average annual return of 21.79%. Currently, Boston Scientific has a market capitalization of $58.91 billion.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2022

Upgrades

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

This Foreboding Sign Looms Over Boston Scientific's Chart

If history is any guide, there may be trouble ahead for shares of Boston Scientific (NYSE:BSX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

5 Analysts Have This to Say About Boston Scientific

Boston Scientific (NYSE:BSX) has observed the following analyst ratings within the last quarter:

Benzinga

Boston Scientific Jumps On Upbeat Q2, FY22 Guidance

Boston Scientific Corp (NYSE:BSX) generated net sales of $3.026 billion in Q1 FY22, beating the Wall Street estimate of $2.95 billion. Sales increased 10% Y/Y on a reported basis, 12.6% on an operational basis, and 9.7% on an organic basis, better than the management estimate of approximately 5% - 8%. The Company achieved…

Benzinga

Recap: Boston Scientific Q1 Earnings

Boston Scientific (NYSE:BSX) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Boston Scientific reported in-line EPS of $0.39 versus an estimate of $0.39.

Benzinga

Hopeful Golden Cross Forms On Boston Scientific's Chart

If history is any guide, there may be good fortune ahead for shares of Boston Scientific (NYSE:BSX). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga

What 5 Analyst Ratings Have To Say About Boston Scientific

Benzinga

Why Is Boston Scientific Stock Trading Lower Premarket Today?

Boston Scientific Corp (NYSE: BSX) generated

1 2 3 4

People

Vujcic

14 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.